Page last updated: 2024-08-21

alpha-aminopyridine and Proteus Syndrome

alpha-aminopyridine has been researched along with Proteus Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Biesecker, LG; de Moya, AJ; Hodges, MB; Ours, CA; Sapp, JC1
Abbadessa, G; Collins, CD; Crown, J; Fagotti, A; Gullo, G; Kazakin, J; Leoni, C; Onesimo, R; Ranieri, C; Resta, N; Scambia, G; Schwartz, B; Zampino, G1
Biesecker, LG; Ferrari, D; Lindhurst, MJ; Savage, RE; Yourick, MR; Yu, Y1

Other Studies

3 other study(ies) available for alpha-aminopyridine and Proteus Syndrome

ArticleYear
Case report: five-year experience of AKT inhibition with miransertib (MK-7075) in an individual with Proteus syndrome.
    Cold Spring Harbor molecular case studies, 2021, Volume: 7, Issue:6

    Topics: Aminopyridines; Humans; Imidazoles; Male; Proteus Syndrome; Proto-Oncogene Proteins c-akt

2021
First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinoma.
    American journal of medical genetics. Part A, 2019, Volume: 179, Issue:7

    Topics: Adolescent; Aminopyridines; Female; Humans; Imidazoles; Mutation; Ovarian Neoplasms; Protein Kinase Inhibitors; Proteus Syndrome; Proto-Oncogene Proteins c-akt

2019
Repression of AKT signaling by ARQ 092 in cells and tissues from patients with Proteus syndrome.
    Scientific reports, 2015, Dec-11, Volume: 5

    Topics: Aminopyridines; Becaplermin; Cell Survival; Cells, Cultured; Humans; Imidazoles; Mutation; Phosphorylation; Protein Kinase Inhibitors; Proteus Syndrome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-sis; Signal Transduction

2015